Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_658df3b9d24eb5224b37aaf605741db6 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
filingDate |
2010-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b797cb97157016942d616183ad74186 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52c8a96ba6ea671865e3f29cd57cda0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2d3e74eb083478f77b96039caf6b42a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35b3eec34169a5ac4a2bfc54cce9bca5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4833a15bfdf553d8b45fabeca23e5184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c35dbb62410ef599ebaa864281dbb0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5df8ca406809269a529af67ff90d1c5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcbaf0d8ff1a66ae5d8442e841847a70 |
publicationDate |
2012-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20120087875-A |
titleOfInvention |
JP receptor-activated glucagon compound |
abstract |
Glucagon peptides having increased GIP activity and optionally GIP-1 and / or glucagon activity are provided. In certain embodiments, a C-terminal extended glucagon peptide is provided that comprises an amino acid sequence substantially similar to natural glucagon. |
priorityDate |
2009-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |